Selected research
Market Analysis & Forecast
Global MRI Contrast Agents Market Analysis and Forecast 2026-2032
Market perspective
The global MRI Contrast Agents market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
MRI Contrast Agents's global sales reached XX (Liter) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned Bayer as the global sales leader, a title it has maintained for several consecutive years. Notably, Bayer's performance in primary markets is also remarkable. In the Chinese market, sales were XX (Liter), a change of XX% from the previous year. In Europe, sales were XX (Liter), showing a year-on-year of XX%. In the US, sales were XX (Liter), a year-on-year change of XX%.
The major global manufacturers in the MRI Contrast Agents market include Bayer, Guerbet Group, Bracco Imaging, GE Healthcare, BeiLu Pharma and Hengrui Medicine, etc. In 2025, the top three vendors accounted for approximately % of the revenue.
Read the full market overview
In terms of production side, this report researches the MRI Contrast Agents production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.
In terms of consumption side, this report focuses on the sales of MRI Contrast Agents by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.
This report presents an overview of global market for MRI Contrast Agents, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of MRI Contrast Agents, also provides the consumption of main regions and countries. Of the upcoming market potential for MRI Contrast Agents, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the MRI Contrast Agents sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global MRI Contrast Agents market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for MRI Contrast Agents sales, projected growth trends, production technology, application and end-user industry.
MRI Contrast Agents Segment by Company
Bayer
Guerbet Group
Bracco Imaging
GE Healthcare
BeiLu Pharma
Hengrui Medicine
MRI Contrast Agents Segment by Type
Gadobutrol
Gadoterate Meglumine
Gadobenate Dimeglumine
Gadopentetate Dimeglumine
Gadoteridol
Gadodiamine
Others
MRI Contrast Agents Segment by Application
Hospitals
Clinics
MRI Contrast Agents Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global MRI Contrast Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of MRI Contrast Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of MRI Contrast Agents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: MRI Contrast Agents production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 4: Sales (consumption), revenue of MRI Contrast Agents in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 5: Detailed analysis of MRI Contrast Agents manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, MRI Contrast Agents sales, revenue, price, gross margin, and recent development, etc.
Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 11: China by type, by application, sales, and revenue for each segment.
Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 15: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Gadobutrol
- Gadoterate Meglumine
- Gadobenate Dimeglumine
- Gadopentetate Dimeglumine
- Gadoteridol
- Gadodiamine
- Others
Applications
- Hospitals
- Clinics
Companies covered
- Bayer
- Guerbet Group
- Bracco Imaging
- GE Healthcare
- BeiLu Pharma
- Hengrui Medicine
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 MRI Contrast Agents Market by Type
- 1.2.1 Global MRI Contrast Agents Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Gadobutrol
- 1.2.3 Gadoterate Meglumine
- 1.2.4 Gadobenate Dimeglumine
- 1.2.5 Gadopentetate Dimeglumine
- 1.2.6 Gadoteridol
- 1.2.7 Gadodiamine
- 1.2.8 Others
- 1.3 MRI Contrast Agents Market by Application
- 1.3.1 Global MRI Contrast Agents Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospitals
- 1.3.3 Clinics
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 MRI Contrast Agents Market Dynamics
- 2.1 MRI Contrast Agents Industry Trends
- 2.2 MRI Contrast Agents Industry Drivers
- 2.3 MRI Contrast Agents Industry Opportunities and Challenges
- 2.4 MRI Contrast Agents Industry Restraints
3 Global MRI Contrast Agents Production Overview
- 3.1 Global MRI Contrast Agents Production Capacity (2021-2032)
- 3.2 Global MRI Contrast Agents Production by Region: 2021 VS 2025 VS 2032
- 3.3 Global MRI Contrast Agents Production by Region
- 3.3.1 Global MRI Contrast Agents Production by Region (2021-2026)
- 3.3.2 Global MRI Contrast Agents Production by Region (2027-2032)
- 3.3.3 Global MRI Contrast Agents Production Market Share by Region (2021-2032)
- 3.4 North America
- 3.5 Europe
- 3.6 China
- 3.7 Japan
4 Global Market Growth Prospects
- 4.1 Global MRI Contrast Agents Revenue Estimates and Forecasts (2021-2032)
- 4.2 Global MRI Contrast Agents Revenue by Region
- 4.2.1 Global MRI Contrast Agents Revenue by Region: 2021 VS 2025 VS 2032
- 4.2.2 Global MRI Contrast Agents Revenue by Region (2021-2026)
- 4.2.3 Global MRI Contrast Agents Revenue by Region (2027-2032)
- 4.2.4 Global MRI Contrast Agents Revenue Market Share by Region (2021-2032)
- 4.3 Global MRI Contrast Agents Sales Estimates and Forecasts 2021-2032
- 4.4 Global MRI Contrast Agents Sales by Region
- 4.4.1 Global MRI Contrast Agents Sales by Region: 2021 VS 2025 VS 2032
- 4.4.2 Global MRI Contrast Agents Sales by Region (2021-2026)
- 4.4.3 Global MRI Contrast Agents Sales by Region (2027-2032)
- 4.4.4 Global MRI Contrast Agents Sales Market Share by Region (2021-2032)
- 4.5 North America
- 4.6 Europe
- 4.7 China
- 4.8 Asia (Excluding China)
- 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
- 5.1 Global MRI Contrast Agents Revenue by Manufacturers
- 5.1.1 Global MRI Contrast Agents Revenue by Manufacturers (2021-2026)
- 5.1.2 Global MRI Contrast Agents Revenue Market Share by Manufacturers (2021-2026)
- 5.1.3 Global MRI Contrast Agents Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 5.2 Global MRI Contrast Agents Sales by Manufacturers
- 5.2.1 Global MRI Contrast Agents Sales by Manufacturers (2021-2026)
- 5.2.2 Global MRI Contrast Agents Sales Market Share by Manufacturers (2021-2026)
- 5.2.3 Global MRI Contrast Agents Manufacturers Sales Share Top 10 and Top 5 in 2025
- 5.3 Global MRI Contrast Agents Sales Price by Manufacturers (2021-2026)
- 5.4 Global MRI Contrast Agents Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 5.5 Global MRI Contrast Agents Key Manufacturers Manufacturing Sites & Headquarters
- 5.6 Global MRI Contrast Agents Manufacturers, Product Type & Application
- 5.7 Global MRI Contrast Agents Manufacturers Commercialization Time
- 5.8 Market Competitive Analysis
- 5.8.1 Global MRI Contrast Agents Market CR5 and HHI
- 5.8.2 2025 MRI Contrast Agents Tier 1, Tier 2, and Tier 3
6 MRI Contrast Agents Market by Type
- 6.1 Global MRI Contrast Agents Revenue by Type
- 6.1.1 Global MRI Contrast Agents Revenue by Type (2021-2032) & (US$ Million)
- 6.1.2 Global MRI Contrast Agents Revenue Market Share by Type (2021-2032)
- 6.2 Global MRI Contrast Agents Sales by Type
- 6.2.1 Global MRI Contrast Agents Sales by Type (2021-2032) & (Liter)
- 6.2.2 Global MRI Contrast Agents Sales Market Share by Type (2021-2032)
- 6.3 Global MRI Contrast Agents Price by Type
7 MRI Contrast Agents Market by Application
- 7.1 Global MRI Contrast Agents Revenue by Application
- 7.1.1 Global MRI Contrast Agents Revenue by Application (2021-2032) & (US$ Million)
- 7.1.2 Global MRI Contrast Agents Revenue Market Share by Application (2021-2032)
- 7.2 Global MRI Contrast Agents Sales by Application
- 7.2.1 Global MRI Contrast Agents Sales by Application (2021-2032) & (Liter)
- 7.2.2 Global MRI Contrast Agents Sales Market Share by Application (2021-2032)
- 7.3 Global MRI Contrast Agents Price by Application
8 Company Profiles
- 8.1 Bayer
- 8.1.1 Bayer Company Information
- 8.1.2 Bayer Business Overview
- 8.1.3 Bayer MRI Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.1.4 Bayer MRI Contrast Agents Product Portfolio
- 8.1.5 Bayer Recent Developments
- 8.2 Guerbet Group
- 8.2.1 Guerbet Group Company Information
- 8.2.2 Guerbet Group Business Overview
- 8.2.3 Guerbet Group MRI Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.2.4 Guerbet Group MRI Contrast Agents Product Portfolio
- 8.2.5 Guerbet Group Recent Developments
- 8.3 Bracco Imaging
- 8.3.1 Bracco Imaging Company Information
- 8.3.2 Bracco Imaging Business Overview
- 8.3.3 Bracco Imaging MRI Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.3.4 Bracco Imaging MRI Contrast Agents Product Portfolio
- 8.3.5 Bracco Imaging Recent Developments
- 8.4 GE Healthcare
- 8.4.1 GE Healthcare Company Information
- 8.4.2 GE Healthcare Business Overview
- 8.4.3 GE Healthcare MRI Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.4.4 GE Healthcare MRI Contrast Agents Product Portfolio
- 8.4.5 GE Healthcare Recent Developments
- 8.5 BeiLu Pharma
- 8.5.1 BeiLu Pharma Company Information
- 8.5.2 BeiLu Pharma Business Overview
- 8.5.3 BeiLu Pharma MRI Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.5.4 BeiLu Pharma MRI Contrast Agents Product Portfolio
- 8.5.5 BeiLu Pharma Recent Developments
- 8.6 Hengrui Medicine
- 8.6.1 Hengrui Medicine Company Information
- 8.6.2 Hengrui Medicine Business Overview
- 8.6.3 Hengrui Medicine MRI Contrast Agents Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.6.4 Hengrui Medicine MRI Contrast Agents Product Portfolio
- 8.6.5 Hengrui Medicine Recent Developments
9 North America
- 9.1 North America MRI Contrast Agents Market Size by Type
- 9.1.1 North America MRI Contrast Agents Revenue by Type (2021-2032)
- 9.1.2 North America MRI Contrast Agents Sales by Type (2021-2032)
- 9.1.3 North America MRI Contrast Agents Price by Type (2021-2032)
- 9.2 North America MRI Contrast Agents Market Size by Application
- 9.2.1 North America MRI Contrast Agents Revenue by Application (2021-2032)
- 9.2.2 North America MRI Contrast Agents Sales by Application (2021-2032)
- 9.2.3 North America MRI Contrast Agents Price by Application (2021-2032)
- 9.3 North America MRI Contrast Agents Market Size by Country
- 9.3.1 North America MRI Contrast Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 North America MRI Contrast Agents Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 North America MRI Contrast Agents Price by Country (2021-2032)
- 9.3.4 United States
- 9.3.5 Canada
- 9.3.6 Mexico
10 Europe
- 10.1 Europe MRI Contrast Agents Market Size by Type
- 10.1.1 Europe MRI Contrast Agents Revenue by Type (2021-2032)
- 10.1.2 Europe MRI Contrast Agents Sales by Type (2021-2032)
- 10.1.3 Europe MRI Contrast Agents Price by Type (2021-2032)
- 10.2 Europe MRI Contrast Agents Market Size by Application
- 10.2.1 Europe MRI Contrast Agents Revenue by Application (2021-2032)
- 10.2.2 Europe MRI Contrast Agents Sales by Application (2021-2032)
- 10.2.3 Europe MRI Contrast Agents Price by Application (2021-2032)
- 10.3 Europe MRI Contrast Agents Market Size by Country
- 10.3.1 Europe MRI Contrast Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 10.3.2 Europe MRI Contrast Agents Sales by Country (2021 VS 2025 VS 2032)
- 10.3.3 Europe MRI Contrast Agents Price by Country (2021-2032)
- 10.3.4 Germany
- 10.3.5 France
- 10.3.6 U.K.
- 10.3.7 Italy
- 10.3.8 Russia
- 10.3.9 Spain
- 10.3.10 Netherlands
- 10.3.11 Switzerland
- 10.3.12 Sweden
11 China
- 11.1 China MRI Contrast Agents Market Size by Type
- 11.1.1 China MRI Contrast Agents Revenue by Type (2021-2032)
- 11.1.2 China MRI Contrast Agents Sales by Type (2021-2032)
- 11.1.3 China MRI Contrast Agents Price by Type (2021-2032)
- 11.2 China MRI Contrast Agents Market Size by Application
- 11.2.1 China MRI Contrast Agents Revenue by Application (2021-2032)
- 11.2.2 China MRI Contrast Agents Sales by Application (2021-2032)
- 11.2.3 China MRI Contrast Agents Price by Application (2021-2032)
12 Asia (Excluding China)
- 12.1 Asia MRI Contrast Agents Market Size by Type
- 12.1.1 Asia MRI Contrast Agents Revenue by Type (2021-2032)
- 12.1.2 Asia MRI Contrast Agents Sales by Type (2021-2032)
- 12.1.3 Asia MRI Contrast Agents Price by Type (2021-2032)
- 12.2 Asia MRI Contrast Agents Market Size by Application
- 12.2.1 Asia MRI Contrast Agents Revenue by Application (2021-2032)
- 12.2.2 Asia MRI Contrast Agents Sales by Application (2021-2032)
- 12.2.3 Asia MRI Contrast Agents Price by Application (2021-2032)
- 12.3 Asia MRI Contrast Agents Market Size by Country
- 12.3.1 Asia MRI Contrast Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 Asia MRI Contrast Agents Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 Asia MRI Contrast Agents Price by Country (2021-2032)
- 12.3.4 Japan
- 12.3.5 South Korea
- 12.3.6 India
- 12.3.7 Australia
- 12.3.8 Taiwan
- 12.3.9 Southeast Asia
13 South America, Middle East and Africa
- 13.1 SAMEA MRI Contrast Agents Market Size by Type
- 13.1.1 SAMEA MRI Contrast Agents Revenue by Type (2021-2032)
- 13.1.2 SAMEA MRI Contrast Agents Sales by Type (2021-2032)
- 13.1.3 SAMEA MRI Contrast Agents Price by Type (2021-2032)
- 13.2 SAMEA MRI Contrast Agents Market Size by Application
- 13.2.1 SAMEA MRI Contrast Agents Revenue by Application (2021-2032)
- 13.2.2 SAMEA MRI Contrast Agents Sales by Application (2021-2032)
- 13.2.3 SAMEA MRI Contrast Agents Price by Application (2021-2032)
- 13.3 SAMEA MRI Contrast Agents Market Size by Country
- 13.3.1 SAMEA MRI Contrast Agents Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 13.3.2 SAMEA MRI Contrast Agents Sales by Country (2021 VS 2025 VS 2032)
- 13.3.3 SAMEA MRI Contrast Agents Price by Country (2021-2032)
- 13.3.4 Brazil
- 13.3.5 Argentina
- 13.3.6 Chile
- 13.3.7 Colombia
- 13.3.8 Peru
- 13.3.9 Saudi Arabia
- 13.3.10 Israel
- 13.3.11 UAE
- 13.3.12 Turkey
- 13.3.13 Iran
- 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
- 14.1 MRI Contrast Agents Value Chain Analysis
- 14.1.1 MRI Contrast Agents Key Raw Materials
- 14.1.2 Raw Materials Key Suppliers
- 14.1.3 Manufacturing Cost Structure
- 14.1.4 MRI Contrast Agents Production Mode & Process
- 14.2 MRI Contrast Agents Sales Channels Analysis
- 14.2.1 Direct Comparison with Distribution Share
- 14.2.2 MRI Contrast Agents Distributors
- 14.2.3 MRI Contrast Agents Customers
15 Concluding Insights
16 Appendix
- 16.1 Reasons for Doing This Study
- 16.2 Research Methodology
- 16.3 Research Process
- 16.4 Authors List of This Report
- 16.5 Data Source
- 16.5.1 Secondary Sources
- 16.5.2 Primary Sources
- 16.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst